Results 91 to 100 of about 1,295 (151)

Metagenomic Next-Generation Sequencing (mNGS) of cerebrospinal fluid for diagnosis of human herpesvirus 6B encephalitis following transplantation for severe aplastic anemia

open access: yesJournal of Infection in Developing Countries
Introduction: Human herpesvirus 6B (HHV-6B) encephalitis is common in immunosuppressed patients and presents a diagnostic challenge for physicians.
Kaile Zhang   +5 more
doaj   +1 more source

Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation

open access: yes, 2002
The present study compared foscarnet with ganciclovir for preemptive therapy of cytomegalovirus (CMV) infection after allogeneic blood or marrow stem cell transplantation (SCT). Patients with CMV infection, as detected by weekly antigenemia or polymerase
Reusser, P   +9 more
core   +1 more source

Effect of Prophylactic Administration of Foscarnet for HHV-6 Encephalitis in Adult Single Cord Blood Transplantation

open access: yes
Background: HHV-6 encephalitis is a serious complication after allogeneic hematopoietic stem cell transplantation. Whether foscarnet prophylaxis improves outcomes after unrelated cord blood transplantation (UCBT), particularly under systemic steroid ...
Kanda, Junya   +8 more
core   +1 more source

Foscarnet therapy for congenital cytomegalovirus liver fibrosis following prenatal ascites

open access: yes, 2004
We report on an infant with multi-system disease including liver fibrosis, right microphthalmia with cataract, interstitial pneumonitis, and hyperechoic lesions in the basal ganglia and in the periventricular and thalamic regions.
L. Maranghi   +6 more
core   +1 more source

Poster Sessions

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Phase I-II Trial of Foscarnet for Prevention of Cytomegalovirus Infection in Autologous and Allogeneic Marrow Transplant Recipients [PDF]

open access: yes, 2017
The safety and efficacy of foscarnet for prevention of cytomegalovirus (CMV) infection was evaluated in 19 CMV-seropositive bone marrow transplant (BMT) recipients.
Reusser, Pierre   +3 more
core  

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Développement d'un test colorimétrique pour tester la sensibilité de l'ADN polymérase du cytomégalovirus humain au foscarnet

open access: yes, 2005
We described a colorimetric method to determine the biochemical phenotype of wild-type and mutated cytomegalovirus (HCMV) DNA polymerases by measuring the incorporation of digoxigenin-labelled nucleotides into the growing DNA chain.
A.M. Fillet   +6 more
core   +1 more source

Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG Protocol 093)

open access: yes, 1994
Objective: To document response to foscarnet salvage therapy in patients with cytomegalovirus (CMV) retinitis who are intolerant of or resistant to ganciclovir.
Murphy, Robert L.   +14 more
core   +1 more source

Clinical and genotypic characteristics of antiviral-resistant herpes simplex virus 1 and 2 infections: a case series

open access: yesBMC Infectious Diseases
Antiviral-resistant herpes simplex virus (HSV) infections predominantly occur in immunocompromised individuals and represent a major therapeutic challenge.
Racha Ibrahim   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy